. What Are Ion Channels We all think differently and use different words/associations to describe the same thing. See how different scientists define ion channels. Fundamentals Nobel Prizes for the discoveries concerning ion channels Fundamentals History Of Ion Channels Fundamentals Ion Channel News: 09/06/2021 Caraway Therapeutics and AbbVie join forces to develop novel TMEM175 modulators for Parkinson’s disease and other neurodegenerative disorders 30/04/2021 Aerie Pharmaceuticals completes enrollment of its Phase 2b clinical trial of AR-15512 (TRPM8 agonist) ophthalmic solution for the treatment of patients with dry eye disease 07/04/2021 Metrion Biosciences raises £2.7m and adds GLP cardiac safety services to the suite of ion channel drug discovery services 12/03/2021 CalciMedica Raises $21 Million in Series D Financing to support the clinical development of CRAC channel inhibitors 22/12/2020 FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations 22/12/2020 Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders 18/12/2020 Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19 17/12/2020 Cadent Therapeutics and its ion channel programs to be acquired by Novartis 16/12/2020 Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain Read more news here Professor Irina Vetter on pain, stinging trees and ion channels in Australia INTERVIEWS Ion Channel DRUGS Resource Ion Channel COMPANIES Resource Ion Channel LABS Resource Membrane Transport Infographic Electrical Signals Infographic Permeability Of Lipid Bilayers Infographic
What Are Ion Channels We all think differently and use different words/associations to describe the same thing. See how different scientists define ion channels. Fundamentals
09/06/2021 Caraway Therapeutics and AbbVie join forces to develop novel TMEM175 modulators for Parkinson’s disease and other neurodegenerative disorders 30/04/2021 Aerie Pharmaceuticals completes enrollment of its Phase 2b clinical trial of AR-15512 (TRPM8 agonist) ophthalmic solution for the treatment of patients with dry eye disease 07/04/2021 Metrion Biosciences raises £2.7m and adds GLP cardiac safety services to the suite of ion channel drug discovery services 12/03/2021 CalciMedica Raises $21 Million in Series D Financing to support the clinical development of CRAC channel inhibitors 22/12/2020 FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations 22/12/2020 Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders 18/12/2020 Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19 17/12/2020 Cadent Therapeutics and its ion channel programs to be acquired by Novartis 16/12/2020 Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain
